Cardiology
Podcasts
MDedge Daily News: Improving wearable cardioverter defibrillators
And alirocumab cuts deaths in post–acute coronary syndrome patients.
Conference Coverage
Genotype did not significantly affect evacetrapib response
What’s AA genotype got to do with it? Nothing, it turns out.
Conference Coverage
CECCY: Carvedilol didn’t curb cardiotoxicity in breast cancer patients
ORLANDO – “In short follow up, we can see cardiotoxicity appearing, and we know we have to treat it promptly to prevent cardiac events.”
Conference Coverage
Wearable defibrillator cuts mortality in post-MI patients
ORLANDO – It may be time to upgrade guidelines.
Conference Coverage
Ticagrelor noninferior to clopidogrel in terms of major bleeds in STEMI
New STEMI data answer some but not all questions.
Conference Coverage
ODYSSEY Outcomes trial redefines secondary cardiovascular prevention
ORLANDO – “I believe this trial is going to change practice.” – Valentin Fuster, MD
Video
ODYSSEY Outcomes results build on FOURIER
ODYSSEY Outcomes proves benefit of PCSK9 inhibition, but small differences from FOURIER are concerning.
Conference Coverage
VEST: Closer tailoring might boost wearable cardioverter defibrillator’s benefit
VEST showed a wearable cardioverter defibrillator cut all-cause deaths but not arrhythmia deaths, suggesting a need for greater patient targeting...
Video
Post-ACS death lowered in ODYSSEY Outcomes
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
Primary Care Medical Abstracts
Abstract: A Test in Context: Lipid Profile, Fasting Versus Nonfasting
This Danish author reviews the impact of a fasting versus nonfasting state on lipid profile testing.
Conference Coverage
Revascularization in paraplegics best performed with PCI
WASHINGTON – The first study of its kind showed big differences between CABG and PCI.